Identification of ALEKSIN as a novel multi-IRF inhibitor of IRF- and STAT-mediated transcription in vascular inflammation and atherosclerosis

Cardiovascular diseases (CVDs) include atherosclerosis, which is an inflammatory disease of large and medium vessels that leads to atherosclerotic plaque formation. The key factors contributing to the onset and progression of atherosclerosis include the pro-inflammatory cytokines interferon (IFN)α a...

Descripció completa

Dades bibliogràfiques

Autors principals:	Aleksandra Antonczyk, Katarzyna Kluzek, Natalia Herbich, Mahdi Eskandarian Boroujeni, Bart Krist, Dorota Wronka, Anna Karlik, Lukasz Przybyl, Adam Plewinski, Joanna Wesoly, Hans A. R. Bluyssen
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2025-01-01
Col·lecció:	Frontiers in Pharmacology
Matèries:	interferon regulatory factor signal transducer and activator of transcription interferon Toll-like receptor vascular inflammation in silico docking
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1471182/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!